Difficulty: Medium
Average Score: 91%
Testbank
A patient with Von Willebrand disease (vWD) has experienced recent changes in bowel function that suggest the need for a screening colonoscopy. What intervention should be performed in anticipation of this procedure?
Correct answer
D
Rationale
The patient should be given necessary clotting factors before the procedure.
In patients with Von Willebrand disease, there is a deficiency in von Willebrand factor, which is crucial for platelet function and clotting. Administering the necessary clotting factors prior to a colonoscopy helps to prevent excessive bleeding during the procedure, ensuring patient safety and effective management of their condition.
A: The patient should not undergo the normal bowel cleansing protocol prior to the procedure. This option fails because appropriate bowel cleansing is typically necessary for a colonoscopy, and it does not address the need for managing bleeding risk.
B: The patient should receive a unit of fresh-frozen plasma 48 hours before the procedure. While fresh-frozen plasma can provide clotting factors, it is not the most effective or immediate intervention compared to administering specific clotting factors closer to the procedure.
C: The patient should be admitted to the surgical unit on the day before the procedure. Admission the day before does not directly address the need for clotting factor administration, which is critical for preventing bleeding complications during the colonoscopy.
In patients with Von Willebrand disease, there is a deficiency in von Willebrand factor, which is crucial for platelet function and clotting. Administering the necessary clotting factors prior to a colonoscopy helps to prevent excessive bleeding during the procedure, ensuring patient safety and effective management of their condition.
A: The patient should not undergo the normal bowel cleansing protocol prior to the procedure. This option fails because appropriate bowel cleansing is typically necessary for a colonoscopy, and it does not address the need for managing bleeding risk.
B: The patient should receive a unit of fresh-frozen plasma 48 hours before the procedure. While fresh-frozen plasma can provide clotting factors, it is not the most effective or immediate intervention compared to administering specific clotting factors closer to the procedure.
C: The patient should be admitted to the surgical unit on the day before the procedure. Admission the day before does not directly address the need for clotting factor administration, which is critical for preventing bleeding complications during the colonoscopy.